Table 1. Defining the essential HDAC binding elements of ortho-aminoanilides.
|
HDAC isoform inhibition IC50
a
(μM) |
Ligand efficiency b (ligE) | |||
| Compound | Structure | HDAC1 | HDAC2 | HDAC3 | HDAC1/HDAC2 |
| Cl-994 |
|
0.041 ± 0.012 | 0.147 ± 0.066 | 0.046 ± 0.018 | 0.37/0.34 |
| 1 |
|
0.001 ± 0.001 | 0.013 ± 0.009 | 0.398 ± 0.105 | 0.36/0.32 |
| Residence time T 1/2 (min) | |||||
| >2400 | ∼4800 | ∼1200 | |||
| 2 |
|
0.023 ± 0.008 | 0.129 ± 0.006 | 1.68 ± 0.26 | 0.36/0.33 |
| 3 |
|
0.355 ± 0.012 | 8.71 ± 3.16 | 0.665 ± 0.063 | 0.40/0.32 |
| 4 |
|
>33.33 | >33.33 | >33.33 | |
aValues are the mean of a minimum of two experiments. Data are shown as IC50 values in μM ± standard deviation. Compounds were tested in duplicate in a 12-point dose curve with 3-fold serial dilution starting from 33.33 μM.
bLigand efficiency (ligE) = (–log IC50)/number of non-hydrogen atoms.